| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |